The Latest Breaking News from JJ.

Pharmaceutical giant’s payout settles allegations it misled consumers about safety of its talcum-based powder products.

As tens of thousands of lawsuits related to Johnson & Johnson’s Baby Powder flood US courts, many women are coming forward claiming that talc-based makeup gave them asbestos-related mesothelioma. Why is talc still present in almost all cosmetics?

Scientists have offered a new explanation for why COVID-19 vaccines that contained adenoviruses carried a rare-but-serious risk of blood clotting.

The exit of a Johnson & Johnson exec raises an age-old question about women's ambition.

Joe Wolk, with J&J for over 25 years, talks about his path and the company's focus on innovation.

In a series of moves experts say signal a shift in how developing countries deal with pharmaceuticals, South Africa, Colombia and others have recently adopted a more combative approach towards drugmakers, pushing back on policies that deny treatment to millions of people with tuberculosis and HIV

The legendary value investor slashed two consistent dividend-paying stocks from Berkshire Hathaway's portfolio in the latest quarter, according to regulatory filings.

This week’s episode of Fortune‘s Leadership Next podcast features conversations from the Fortune CEO Initiative conference.

“The announcement will finally pave the way for unfettered access to affordable generic versions of bedaquiline for all people”